Prospective comparison of flecainide versus sotalol for immediate cardioversion of atrial fibrillation

American Journal of Cardiology

Volumn 81, Issue 12, 1998, Pages 1450-1454

  Reisinger, Johann ^a   Gatterer, Edmund ^b   Heinze, Georg ^b   Wiesinger, Kurt ^b   Zeindlhofer, Eduard ^b   Gattermeier, Martin ^b   Poelzl, Gerhard ^b   Kratzer, Horst ^b   Ebner, Anton ^b   Hohenwallner, Wolfgang ^b   Lenz, Kurt ^b   Slany, Joerg ^b   Kuhn, Peter ^b  

^a Krankenhaus der Barmherzigen Schwestern Wien Betriebsgesellschaft   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLECAINIDE; SOTALOL;

ARTICLE; CARDIOVERSION; CLINICAL TRIAL; CONTROLLED STUDY; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE CONTRACTION; HUMAN; HYPOKALEMIA; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROBABILITY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SINUS RHYTHM;

AGE FACTORS; AGED; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLECAINIDE; HUMANS; INFUSIONS, INTRAVENOUS; LOGISTIC MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEX FACTORS; SINGLE-BLIND METHOD; SOTALOL; TIME FACTORS; TREATMENT OUTCOME;

EID: 0032526032     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)00223-9     Document Type: Article

References (29)

1. 1. Borgeat A, Goy JJ, Maendly R, Kaufmann U, Grbic M, Sigwart U. Flecainide versus quinidine for cardioversion of atrial fibrillation to sinus rhythm. Am J Cardiol 1986;58:496-498.
2. 2. Suttorp MJ, Kingma JH, Lie-A-Huen L, Mast EG. Intravenous flecainide versus verapamil for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. Am J Cardiol 1989;63:693-696.
3. 3. Wafa SS, Ward DE, Parker J, Camm AJ. Efficacy of flecainide acetate for atrial arrhythmias following coronary artery bypass grafting. Am J Cardiol 1989;63:1058-1064.
4. 4. Capucci A, Lenzi T, Boriani G, Trisolini G, Binetti N, Cavazza M, Fontana G, Magnani B. Effectiveness of loading oral flecainide for converting recent-onset atrial fibrillation to sinus rhythm in patients without organic heart disease or with only systemic hypertension. Am J Cardiol 1992;70:69-72.
5. 5. Madrid AH, Moro C, Marin-Huerta E, Mestre JL, Novo L, Costa A. Comparison of flecainide and procainamide in cardioversion of atrial fibrillation. Eur Heart J 1993;14:1127-1131.
6. 6. Suttorp MJ, Kingma JH, Jessurun ER, Lie-A-Huen L, van Hemel NM, Lie KI. The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. J Am Coll Cardiol 1990;16:1722-1727.
7. 7. Donovan KD, Power BM, Hockings BEF, Dobb GJ, Lee K-Y. Intravenous flecainide versus amiodarone for recent-onset atrial fibrillation. Am J Cardiol 1995;75:693-697.
8. 8. Campell TJ, Gavaghan TP, Morgan JJ. Intravenous sotalol for the treatment of atrial fibrillation and flutter after cardiopulmonary bypass: comparison with disopyramide and digoxin in a randomised trial. Br Heart J 1985;54:86-90.
9. 9. Hohnloser SH, van de Loo A, Baedeker F. Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine. J Am Coll Cardiol 1995;26:852-858.
10. 10. Halinen MO, Huttunen M, Paakkinen S, Tarssanen L. Comparison of sotalol with digoxin-quinidine for conversion of acute atrial fibrillation to sinus rhythm (the Sotalol-Digoxin-Quinidine Trial). Am J Cardiol 1995;76:495-498.
11. 11. Sung RJ, Tan HL, Karagounis L, Hanyok JJ, Falk R, Platia E, Das G, Hardy SA, and the Sotalol Multicenter Study Group. Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: a multi-center, randomized, double-blind, placebo-controlled study. Am Heart J 1995;129:739-748.
12. 12. Geller NL, Pocock SJ. Interim analyses in randomized clinical trials: ramifications and guidelines for practitioners. Biometrics 1987;43:213-223.
13. 13. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
14. 14. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-170.
15. 15. Hosmer DW, Lemeshow S. Applied Logistic Regression. 1st ed. New York: John Wiley, 1989.
16. 16. Stambler BS, Wood MA, Ellenbogen KA, Perry KT, Wakefield LK, VanderLugt JT, and the Ibutilide Repeat Dose Study Investigators. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Circulation 1996;94:1613-1621.
17. 17. Moe GK. On the multiple wavelet hypothesis of atrial fibrillation. Arch Int Pharmacodyn Ther 1962;140:183-188.
18. 18. Allessie MA, Konings K, Kirchhof CJHJ, Wijffels M. Electrophysiologic mechanisms of perpetuation of atrial fibrillation. Am J Cardiol 1996;77:10A-23A.
19. 19. Rensma PL, Allessie MA, Lammers WJEP, Bonke FIM, Schalij MJ. Length of excitation wave and susceptibility to reentrant atrial arrhythmias in normal concious dogs. Circ Res 1988;62:395-410.
20. 20. Wang Z, Page P, Nattel S. Mechanism of flecainide's antiarrhythmic action in experimental atrial fibrillation. Circ Res 1992;71:271-287.
21. 21. Wang J, Bourne GW, Wang Z, Villemaire C, Talajic M, Nattel S. Comparative mechanisms of antiarrhythmic drug action in experimental atrial fibrillation. Importance of use-dependent effects on refractoriness. Circulation 1993;88: 1030-1044.
22. 22. Juul-Moeller S, Edvardsson N, Rehnquist-Ahlberg N. Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation. Circulation 1990;82:1932-1939.
23. 23. Reimold SC, Cantillon CO, Friedman PL, Antman EM. Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation. Am J Cardiol 1993;71:558-563.
24. 24. Hohnloser SH, Woosley RL. Sotalol. N Engl J Med 1994;331:31-38.
25. 25. Naccarelli GV, Lee KS, Gibson JK, VanderLugt J. Electrophysiology and pharmacology of ibutilide. Am J Cardiol 1996;78(suppl 8A):12A-16A.
26. 26. Wijffels MCEF, Kirchhof CJHJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995;92:1954-1968.
27. 27. Sanfilippo AJ, Abascal VM, Sheehan M, Oertel LB, Harrigan P, Hughes RA, Weyman AE. Atrial enlargement as a consequence of atrial fibrillation. Circulation 1990;82:792-797.
28. 28. Gullestad L, Birkeland K, Molstad P, Moen Hoyer M, Vanberg P, Kjekshus J. The effect of magnesium versus verapamil on supraventricular arrhythmias. Clin Cardiol 1993;16:429-434.
29. 29. Rautaharju PM, Zhou SH, Wong S, Calhoun HP, Berenson GS, Prineas R, Davignon A. Sex differences in the evolution of the electrocardiographic QT interval with age. Can J Cardiol 1992;8:690-695.